MGI
Provider of gene sequencing instruments, reagents, equipment, and related products
About This Fund
MGI is a corporate investor (Suite,) founded in 2016 and headquartered in Shenzhen, Guangdong Province, china. Provider of gene sequencing instruments, reagents, equipment, and related products. The company has multi-omics platforms which include robotic ultrasound systems, sequencers, and automation systems for life science research, agriculture, precision medicine, and healthcare. It also has sequencing reagents, enzymes, an instrument for microbial detection, analyzers, and others. Practice areas include Life Sciences. The firm operates as Genomics and Life Sciences Platforms and Tools. Key investment sectors include Healthcare / HealthTech, Biotech / Biopharma, FoodTech / AgriTech, and DeepTech / Robotics / Hardware.
Investment Focus
Preparing to pitch MGI?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →